Artificial intelligence and scientific publications: Desirable, indispensable or to be banned?

Authors: Delaye, M., L Allemain, G., Bay, J.-O.

Source: Bulletin du cancer. 110(5):470-473

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN632326955&indx=1&recIds=ETOCRN632326955

Rare tumors: Angiosarcoma

Authors: El-Ghazzi, N., Bay, J.-O.

Source: Bulletin du cancer. 110(5):581-588

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN632327092&indx=1&recIds=ETOCRN632327092

A randomized phase III trial comparing trabectedin to best supportive care in patients with pre-treated soft tissue sarcoma: T-SAR, a French Sarcoma Group trial

Authors: Le Cesne, A., Blay, J.-Y., Cupissol, D., Italiano, A., Delcambre, C., Penel, N., Isambert, N., Chevreau, C., Bompas, E., Bertucci, F., Chaigneau, L., Piperno-Neumann, S., Salas, S., Rios, M., Guillemet, C., Bay, J.-O., Ray-Coquard, I., Haddag, L., Bonastre, J., Kapso, R., Fraslin, A., Bouvet, N., Mir, O., Foulon, S.

Source: In Annals of Oncology August 2021 32(8):1034-1044

A phase II of gemcitabine combined with pazopanib followed by pazopanib maintenance, as second-line treatment in patients with advanced leiomyosarcomas: A unicancer French Sarcoma Group study (LMS03 study)

Authors: Pautier, P., Penel, N., Ray-Coquard, I., Italiano, A., Bompas, E., Delcambre, C., Bay, J.-O., Bertucci, F., Delaye, J., Chevreau, C., Cupissol, D., Bozec, L., Eymard, J.-C., Saada, E., Isambert, N., Guillemet, C., Rios, M., Piperno-Neumann, S., Chenuc, G., Duffaud, F.

Source: In European Journal of Cancer January 2020 125:31-37

New drug approval: Loncastuximab tesirine in diffuse large B-cell lymphoma relapsed/refractory after two lines of treatment

Authors: Tauveron-Jalenques, U., Bay, J.-O.

Source: Bulletin du cancer. 110(5):476-477

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN632326978&indx=1&recIds=ETOCRN632326978

Quelles mesures pour maîtriser le risque infectieux chez les patients immunodéprimés ? Recommandations formalisées d’experts

Alternate Title: French recommendations on control measures to reduce the infectious risk in immunocompromised patients (English)

Authors: Zahar, J.-R., Jolivet, S., Adam, H., Dananché, C., Lizon, J., Alfandari, S., Boulestreau, H., Baghdadi, N., Bay, J.-O., Bénéteau, A.-M., Bougnoux, M.-E., Brenier-Pinchart, M.-P., Dalle, J.-H., Fournier, S., Fuzibet, J.-G., Kauffmann-Lacroix, C., Le Guinche, I., Lepelletier, D., Loukili, N., Lory, A., Morvan, M., Oumedaly, R., Ribaud, P., Rohrlich, P., Vanhems, P., Aho, S., Vanjak, D., Gangneux, J.-P.

Source: In Journal de Mycologie Médicale December 2017 27(4):449-456

Extending autologous transplantation as first line therapy in multiple myeloma patients with severe renal impairment: a retrospective study by the SFGM-TC

Authors: Augeul-Meunier, K., Chretien, M.-L., Stoppa, A.-M., Karlin, L., Benboubker, L., Diaz, J. M. T., Mohty, M., Yakoub-Agha, I., Bay, J.-O., Perrot, A.

Source: Bone marrow transplantation. 53(6):749-755

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN616399741&indx=1&recIds=ETOCRN616399741

Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma

Authors: Crocchiolo, R., Ringden, O., Bay, J. O., Blaise, D., Omasic, B., Mazzi, B., Picard, C., Trinca, S., Barkholt, L., Peccatori, J.

Source: BONE MARROW TRANSPLANTATION -BASINGSTOKE THEN LONDON-. 53(2):213-218

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN387865110&indx=1&recIds=ETOCRN387865110

Rituximab, methotrexate, procarbazine, vincristine and intensified cytarabine consolidation for primary central nervous system lymphoma (PCNSL) in the elderly: a LOC network study

Authors: Houillier, C., Ghesquières, H., Chabrot, C. c., Soussain, C., Ahle, G., Choquet, S., Nicolas-Virelizier, E., Bay, J. O., Vargaftig, J., Gaultier, C.

Source: JOURNAL OF NEUROONCOLOGY. 133(2):315-320

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN384913256&indx=1&recIds=ETOCRN384913256

Effect on Survival of Local Ablative Treatment of Metastases from Sarcomas: A Study of the French Sarcoma Group

Authors: Falk, A.T. ^∗, Moureau-Zabotto, L. ^†, Ouali, M. ^‡, Penel, N. ^§, Italiano, A. ^¶, Bay, J.-O. ^{||, ∗∗}, Olivier, T. ^††, Sunyach, M.-P. ^‡‡, Boudou-Roquette, P. ^§§, Salas, S. ^¶¶, Le Maignan, C. ^||||, Ducassou, A. ^∗∗∗, Isambert, N. ^†††, Kalbacher, E. ^‡‡‡, Pan, C. ^§§§, Saada, E. ^∗, Bertucci, F. ^†, Thyss, A. ^∗, Thariat, J. ^∗

Source: In Clinical Oncology January 2015 27(1):48-55

S260: A MATCHED COMPARISON OF TISAGENLECLEUCEL AND AXICABTAGENE CILOLEUCEL CAR T CELLS IN RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A REAL-LIFE LYSA STUDY FROM THE FRENCH DESCAR-T REGISTRY

Authors: Bachy, E., Le Gouill, S., Sesques, P., Di Blasi, R., Guillaume, M., Cartron, G., Beauvais, D., Roulin, L., Gros, F. X., Rubio, M. T., Bories, P., Bay, J. O., Castilla Llorente, C., Choquet, S., Casasnovas, R.-O., Mothy, M., Guidez, S., Joris, M., Loschi, M., Carras, S., Abraham, J., Chauchet, A., Drieu La Rochelle, L., Zerbit, J., Hermine, O., Gastinne, T., Tudesq, J. J., Gat, E., Broussais, F., Thieblemont, C., Houot, R., Morschhauser, F.

Source: HemaSphere. 6:161-162

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100165722892.0x000001&indx=1&recIds=ETOCvdc_100165722892.0x000001

Adjuvant radiotherapy for extremity and trunk wall atypical lipomatous tumor/well-differentiated LPS (ALT/WD-LPS): a French Sarcoma Group (GSF-GETO) study

Authors: Cassier, P.A. ^*, Kantor, G., Bonvalot, S., Lavergne, E., Stoeckle, E., Le Péchoux, C., Meeus, P., Sunyach, M.-P., Vaz, G., Coindre, J.-M., Linassier, C., Labib, A., Delcambre, C., Bay, J.-O., Leyvraz, S., Dubergé, T., Lagrange, J.-L., Duret, A., Blay, J.-Y.

Source: In Annals of Oncology September 2014 25(9):1854-1860

Les glomérulopathies associées aux néoplasies myéloprolifératives

Alternate Title: The myeloproliferative neoplasms-related glomerulopathy (English)

Authors: Bardy, A., Tiple, A., Rabant, M., Kémény, J.-L., El Karoui, K., Hermet, M., Guettrot-Imbert, G., Deteix, P., Bay, J.-O., Aumaître, O., André, M.

Source: In La Revue de médecine interne April 2014 35(4):222-230

Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplant Research

Authors: Potter, V. T., Iacobelli, S., van Biezen, A., Maertens, J., Bourhis, J. H., Passweg, J. R., Yakhoub-Agha, I., Tabrizi, R., Bay, J. O., Chevallier, P.

Source: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 22(9):1615-1620

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN379923939&indx=1&recIds=ETOCRN379923939

TCL1 expression patterns in Waldenstrom macroglobulinemia

Authors: Lemal, R., Bard-Sorel, S., Montrieul, L., Bay, J. O., Ravinet, A., Ledoux-Pilon, A., Cagnard, N., Bailly, S., Morel, P., Charlotte, F.

Source: MODERN PATHOLOGY. 29(1):83-88

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN374162950&indx=1&recIds=ETOCRN374162950

Les médicaments du cancer de vessie

Alternate Title: Medical treatment of bladder cell carcinoma (English)

Authors: Guy, L., Mahammedi, H., Bastide, C., Bruyere, F., Karsenty, G., Bay, J.-O.

Source: In Progres en Urologie November 2013 23(15):1238-1245

Les médicaments du cancer du rein

Alternate Title: Medical treatment of renal cell carcinoma (English)

Authors: Guy, L., Bay, J.-O., Bastide, C., Mahammedi, H., Bruyere, F., Karsenty, G.

Source: In Progres en Urologie November 2013 23(15):1225-1237

HLA-matched allogeneic stem cell transplantation improves outcome of higher risk myelodysplastic syndrome A prospective study on behalf of SFGM-TC and GFM

Authors: Robin, M, Porcher, R, Adès, L, Raffoux, E, Michallet, M, François, S, Cahn, J-Y, Delmer, A, Wattel, E, Vigouroux, S, Bay, J-O, Cornillon, J, Huynh, A, Nguyen, S, Rubio, M-T, Vincent, L, Maillard, N, Charbonnier, A, de Latour, R P, Reman, O, Dombret, H, Fenaux, P, Socié, G

Source: Leukemia. 29(7):1496-1501

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100194149677.0x000001&indx=1&recIds=ETOCvdc_100194149677.0x000001

Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial

Authors: Cesne, A. L., Blay, J. Y., Domont, J., Tresch-Bruneel, E., Chevreau, C., Bertucci, F. o., Delcambre, C., Saada-Bouzid, E., Piperno-Neumann, S., Bay, J. O.

Source: LANCET ONCOLOGY. 16(3):312-319

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN368256716&indx=1&recIds=ETOCRN368256716

Decreased Nonrelapse Mortality after Unrelated Cord Blood Transplantation for Acute Myeloid Leukemia Using Reduced-Intensity Conditioning: A Prospective Phase II Multicenter Trial

Authors: Rio, B., Chevret, S., Vigouroux, S. p., Chevallier, P., Fürst, S., Sirvent, A., Bay, J. O., Socié, G. r., Ceballos, P., Huynh, A.

Source: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 21(3):445-453

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN366983764&indx=1&recIds=ETOCRN366983764